Funded Tech Companies
Anagram Therapeutics
Wondering who provided funding to Anagram Therapeutics? Blackstone joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
Anagram Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
33 Strathmore Rd
Natick, MA 01760
USA
Natick, MA 01760
USA
Phone
Website
Email Address
Company Background Information
Overview
Anagram Therapeutics was founded with the hope and determination to meaningfully improve the lives of people and families affected by rare and life-threatening diseases. We are developing targeted, orally delivered enzyme replacement therapies that seek to improve outcomes, reduce the high treatment burden, and deliver improved safety and tolerability. Anagram is a clinical-stage biopharmaceutical company developing novel, orally delivered enzyme therapeutics for the treatment of diseases caused by malabsorption syndromes and nutrient metabolism disorders -- enzyme deficiencies or genetic mutations that prevent the body from properly metabolizing or absorbing certain fats, sugars, proteins, vitamins, or other key nutrients. These conditions affect infants, children, and adults with congenital diseases worldwide, as well as others who might develop them as part of another illness.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
5/7/2026
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Robert Gallotto
Chief Medical Officer
Evan Bailey
Chief Technical Officer
David Brown
VP - Bus. Development
Hugh Wight
VP - Finance
Tim Caffrey
VP - General Counsel
Julie Constable
VP - Operations
Marcie Clarkin
VP - Regulatory Affairs
Pamela Nelson
Company Investors
- Blackstone
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
The company data above is provided by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs